Xconomy Seattle

EndoGastric Solutions Secures $12,000,000 Series B Funding

  • Feed Type
  • Date
    9/11/2004
  • Company Name
    EndoGastric Solutions
  • Mailing Address
    8210 154th Ave NE Redmond, WA 98052
  • Company Description
    EndoGastric Solutions, Inc. (FKA Esophyx) is the pioneer in endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and obesity. EGS’ mission is to utilize the most current wisdom in gastroenterology and surgery to develop new trans-oral procedures and products to address the largest unmet needs in gastrointestinal diseases.
  • Website
    http://www.endogastricsolutions.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funds will be used to advance the company’s major program into clinical trials and for general corporate expenditures.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Foundation Medical Partners

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.